報價延遲最少15分鐘:2024/06/04 18:44 EDT
|
|
|
|
|
||||||||||||
|
|
|
|
|
0.3644 
|
|
|
| 價值評估 |
|
盈利(現時/預測)
-1.27/-0.97
|
|
企業價值
63.47M
|
| 資產負債 |
|
每股賬面淨值
-0.94
|
| 現金流量 |
|
現金流量率
--
|
| 損益表 |
|
收益
48.54M
|
|
每股收益
1.90
|
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
報價延遲最少15分鐘：2024/06/04 18:44 EDT
同行比較之報價最少15分鐘延遲
|
業務概覽
|
|||
| Centogene NV is a United States-based company engaged in data-driven answers to patients, physicians, and pharmaceutical companies for rare and neurodegenerative diseases. The company operates in two segments: pharmaceutical and diagnostics. Its pharmaceutical segment provides a variety of services to its pharmaceutical partners, including early patient recruitment and identification, epidemiological insights, biomarker discovery, and patient monitoring. Its diagnostics segment provides targeted genetic sequencing and diagnostics services to patients. Its geographic regions are Europe, the Middle East, North America, and Latin America. |